CBU
CRL icon

CIBC Bancorp USA’s Charles River Laboratories CRL Stock Holding History

CIBC Bancorp USA’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Sell
18,763
-6,752
-26% -$1.2M 0.01% 797
2026
Q1 		$4.57M Buy
+25,515
New +$4.73M 0.01% 729
2025
Q3 		$786K Buy
+5,025
New +$798K ﹤0.01% 728

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIBC Bancorp USA's CRL Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Charles River Laboratories (CRL) stake by 26% in Q2 2026, selling an estimated $1.2M and leaving 18,763 shares worth $4.25M. The position accounts for 0.01% of the portfolio, ranked #797.

CIBC Bancorp USA first reported a position in CRL in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.57M in Q1 2026. 531 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • CIBC Bancorp USA held 18,763 shares of Charles River Laboratories worth $4.25M as of Q2 2026.
  • CIBC Bancorp USA sold 6,752 Charles River Laboratories shares in Q2 2026, an estimated $1.2M.
  • Charles River Laboratories made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #797 holding.
  • CIBC Bancorp USA first reported a position in Charles River Laboratories in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Charles River Laboratories position peaked at $4.57M in Q1 2026.
  • 531 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.